Aptevo Therapeutics Inc. Cash and Restricted Cash
Aptevo Therapeutics Inc. (APVO) had Cash and Restricted Cash of $25.33 million as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2023-05-11
- 2023-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $25.33M.
- 2022-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $22.64M.
- 2022-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $22.58M.
- 2022-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $29.98M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2023-03-31 | $25.33M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $22.64M 10-Q · filed 2023-05-11 |
| 2022-09-30 | $22.58M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $29.98M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $36.25M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $46.30M 10-K · filed 2023-03-30 |
| 2021-09-30 | $53.38M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $61.65M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $58.78M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $42.53M 10-K · filed 2022-03-24 |
| 2020-09-30 | $27.50M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $10.15M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $14.79M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $19.95M 10-K · filed 2021-03-31 |
| 2019-09-30 | $25.18M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $28.45M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $44.46M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $38.08M 10-K · filed 2020-03-25 |
| 2018-09-30 | $36.30M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $20.07M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $23.47M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $17.50M 10-K · filed 2019-03-18 |
| 2017-06-30 | $22.67M 10-Q · filed 2018-08-09 |
| 2017-03-31 | $14.41M 10-Q · filed 2018-05-10 |
| 2016-12-31 | $10.08M 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |